Search Results - "Larson Ode, K."

88 Staphylococcus aureus genotype and risk of cystic fibrosis–related diabetes mellitus by Ismael, H., Teresi, M., Ode, K. Larson, Fischer, A.

Get full text

662 Glucose absorption in people with cystic fibrosis by Bowen, E., Ode, K. Larson, Norris, A., Teresi, M., Krogh, J.

Get full text

663 The relationship between HbA1c, glucose management indicator, and average sensor glucose in adults with CF-related diabetes by Ahmed, A., Asirvatham, R., Wang, Q., Vigers, T., Ode, K. Larson, Chan, C., Moheet, A.

Get full text

661 Glycemia and insulin secretion in a large cohort of people with cystic fibrosis by Ode, K. Larson, Vigers, T., Granados, A., Moheet, A., Chan, C.

Get full text

667 Hypoglycemia during extended oral glucose tolerance test in a large cohort of youth and adults with cystic fibrosis by Moheet, A., Chan, C., Granandos, A., Vigers, T., Ode, K. Larson

Get full text

604 Frequency of hepatobiliary abnormalities in young children with CF before and after 6 months of elexacaftor/tezacaftor/ivacaftor: results from the BEGIN Study by Leung, D., O'Rourke, C., Russell, R., Heltshe, S., Buckingham, R., Ode, K. Larson, Zemanick, E., Hoffman, L., Ramsey, B.

Get full text

700 Biological and clinical effects of significantly corrected CFTR function in infants and young children: BEGIN study by Heltshe, S., Hoffman, L., Ode, K. Larson, Zemanick, E., Ratjen, F., Buckingham, R., O'Rourke, C., Russell, R., Ramsey, B.

Get full text

189 Impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis by Granados, A., Chan, C., Vigers, T., Moheet, A., Arbelaez, A., Larson Ode, K.

Get full text

13 A North American provider survey of cystic fibrosis–related diabetes screening practices by Hicks, R., Larson Ode, K., Vigers, T., Martinez, A., Chan, C.

Get full text

600 Changes in fecal pancreatic elastase in children with CF with 6 months of highly effective modulator therapy: Results from the BEGIN study by Dutta, A., Pope, C., O'Rourke, C., Buckingham, R., Russell, R., Heltshe, S., Leung, D., Sullivan, J., Ode, K. Larson, Zemanick, E., Ramsey, B., Hoffman, L.

Get full text

18: Effect of clinical initiation of elexacaftor/tezacaftor/ivacaftor on glucose homeostasis in patients with cystic fibrosis by Granados, A., Moheet, A., Chan, C., Singh, S., Norris, A., Hu, S., Yi, Y., Ode, K. Larson

Get full text

255: Patient and caregiver opinions of airway clearance methods used for cystic fibrosis by Kienenberger, Z., Farber, T., Teresi, M., Milavetz, F., Singh, S., Ode, K. Larson, Thoma, T., Weiner, R., Burlage, K., Fischer, A.

Get full text